HLR

(redirected from Hoffman La Roche)
Category filter:
AcronymDefinition
HLRHome Location Register (register component that interfaces with other components in a GSM and CDMA system)
HLRHarvard Law Review
HLRHome Location Register
HLRHalf-Life Rally (gaming, Half-Life modification)
HLRHidden Line Removal (CAD)
HLRHeavy Lift Replacement (USMC replacement aircraft)
HLRHigh Level Requirement
HLRHoffman La Roche
HLRHeart-Lung Resuscitator
HLRHistoric Lotus Register
HLRHuman Language Resources
HLRHigh Level Reservoir
HLRHigh Level Rescue
HLRHigher Level Reviewer (US DoD)
HLRHorizontal Recirculator (industrial refrigeration)
HLRHustle Loyalty Respect
HLRHonorary Local Representative
HLRHigh Lift Rotor
HLRHobbes, Locke & Rousseau
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Researchers at drug company Hoffman La Roche have identified a group of molecules which can turn p 53 back on.
Project highlights to date include work with Esso, Chevron, Sunoco, 3-M, Dow, DuPont, Merck, Hoffman La Roche, the US Navy, the City of Phoenix, International Paper, Bayer, Weyerhaeuser, Marathon Engineering, Kodak, Syncrude and Tesoro.
Zimmerman spent 10 years with Hoffman La Roche and six years with Pfizer.
Hoffman La Roche Ltd., GlaxoSmithKline plc, Merck KGaA, Novartis AG, Sanofi and Takeda Pharmaceutical Co Ltd.
The US Food and Drug Administration reported on Monday that it has expanded approval for use of Hoffman La Roche Inc's subcutaneous Actemra (tocilizumab) for the treatment of adults with giant cell arteritis.
The company has entered into a collaborative licensing agreement with Incyte and Hoffman La Roche for development of drugs used in the treatment of HIV and Hepatitis C respectively.
She has more than 20 years of experience in haematology and medical oncology, and prior to Quintiles held positions at Pierre Fabre Oncology and Hoffman La Roche. She will report directly to executive vice president and chief operating officer, Mathieu Simon.
Dr Salvador was previously employed as vice president of International Preclinical Development and deputy to the president of International Research and Development at Hoffman La Roche, where he was actively involved in the governing committees that engaged in all aspects of drug discovery and development processes that led to the successful regulatory approvals and commercialisation of numerous drugs.
Recently, Ross has worked Sandoz, Fisons plc and Hoffman La Roche. Previously, he was a member of the board of Celltech Group,Quadrant Healthcare, Allergy Therapeutics, Eden Biodesign, Phadia AB and Silence Therapeutics.